TRASTUZUMAB BEYOND PROGRESSION IN PATIENTS WITH HER-2/NEU POSITIVE METASTATIC BREAST CANCER
Limited data from small retrospective analyses investigating the role of second- line trastuzumab-based treatment suggests a benefitial effect in terms of time to progression for the management of progressive disease following first-line trastuzumab use in patients with Her-2/neu positive disease. H...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2009-01-01
|
| Series: | European Journal of Breast Health |
| Subjects: | |
| Online Access: |
http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/trastuzumab-beyond-progresson-n-patents-wth-her-2-/42563
|